title: Targeted proteomic quantitation of the absolute expression and turnover of cystic fibrosis transmembrane conductance regulator in the apical plasma membrane.
abstract: Deficient chloride transport through cystic fibrosis (CF) transmembrane conductance regulator (CFTR) causes lethal complications in CF patients. CF is the most common autosomal recessive genetic disease, which is caused by mutations in the CFTR gene; thus, CFTR mutants can serve as primary targets for drugs to modulate and rescue the ion channel's function. The first step of drug modulation is to increase the expression of CFTR in the apical plasma membrane (PM); thus, accurate measurement of CFTR in the PM is desired. This work reports a tandem enrichment strategy to prepare PM CFTR and uses a stable isotope labeled CFTR sample as the quantitation reference to measure the absolute amount of apical PM expression of CFTR in CFBE 41o- cells. It was found that CFBE 41o- cells expressing wild-type CFTR (wtCFTR), when cultured on plates, had 2.9 ng of the protein in the apical PM per million cells; this represented 10% of the total CFTR found in the cells. When these cells were polarized on filters, the apical PM expression of CFTR increased to 14%. Turnover of CFTR in the apical PM of baby hamster kidney cells overexpressing wtCFTR (BHK-wtCFTR) was also quantified by targeted proteomics based on multiple reaction monitoring mass spectrometry; wtCFTR had a half-life of 29.0 ± 2.5 h in the apical PM. This represents the first direct measurement of CFTR turnover using stable isotopes. The absolute quantitation and turnover measurements of CFTR in the apical PM can significantly facilitate understanding the disease mechanism of CF and thus the development of new disease-modifying drugs. Absolute CFTR quantitation allows for direct result comparisons among analyses, analysts, and laboratories and will greatly amplify the overall outcome of CF research and therapy.
authors.affiliation: Department of Chemistry, University of Connecticut , Storrs, Connecticut 06269, United States.
authors.forename: Adam J
authors.initials: AJ
authors.lastname: McShane
authors.forename: Bekim
authors.initials: B
authors.lastname: Bajrami
authors.forename: Alex A
authors.initials: AA
authors.lastname: Ramos
authors.forename: Pamela A
authors.initials: PA
authors.lastname: Diego-Limpin
authors.forename: Vahid
authors.initials: V
authors.lastname: Farrokhi
authors.forename: Bonita A
authors.initials: BA
authors.lastname: Coutermarsh
authors.forename: Bruce A
authors.initials: BA
authors.lastname: Stanton
authors.forename: Tim
authors.initials: T
authors.lastname: Jensen
authors.forename: John R
authors.initials: JR
authors.lastname: Riordan
authors.forename: Diana
authors.initials: D
authors.lastname: Wetmore
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Joseloff
authors.forename: Xudong
authors.initials: X
authors.lastname: Yao
mesh_terms: D000818:Animals; D019921:Biotinylation; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism*; D002712:Chlorides / Q000378:metabolism; D006224:Cricetinae; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000737:chemistry / Q000378:metabolism*; D006207:Half-Life; D006801:Humans; D017136:Ion Transport / Q000502:physiology; D007553:Isotope Labeling; D013058:Mass Spectrometry; D008958:Models, Molecular; D040901:Proteomics / Q000379:methods*
chemical_list: D002712:Chlorides; D019005:Cystic Fibrosis Transmembrane Conductance Regulator
keywords: Cystic fibrosis; cystic fibrosis transmembrane conductance regulator; membrane protein quantitation; quantitative proteomics